News
This was the stock's second consecutive day of losses.
12h
Zacks Investment Research on MSNInvestors Heavily Search Pfizer Inc. (PFE): Here is What You Need to KnowPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
3h
Zacks Investment Research on MSNPfizer (PFE) Stock Sinks As Market Gains: Here's WhyPfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
Pfizer Inc. (NYSE:PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...
11don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Council of the Americas, with the support of Pfizer, convenes high-level roundtable discussions across Latin America.
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.
13d
Zacks.com on MSNPfizer's Strong Late-Stage Pipeline Can Drive Long-Term GrowthPFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results